BioNTech SE (BNTX) Raw Materials (2018 - 2021)

BioNTech SE (BNTX) has 4 years of Raw Materials data on file, last reported at $284.0 million in Q4 2021.

• In Q4 2021, Raw Materials rose 437.78% year-over-year to $284.0 million; the TTM figure through Dec 2021 stood at $284.0 million (up 437.78% YoY), while the FY2021 annual figure was $284.0 million, up 437.78% from the prior year.
• Raw Materials advanced to $284.0 million in Q4 2021, from $203.9 million in the prior quarter.
• Across five years, Raw Materials topped out at $284.0 million in Q4 2021 and bottomed at $5.1 million in Q4 2018.
• A 4-year average of $111.0 million and a median of $52.8 million in 2020 frame the typical range for Raw Materials.
• Annual changes were most pronounced in 2019 — Raw Materials soared 77.72% — and 2020, when it soared 481.86%.
• Year by year, Raw Materials stood at $5.1 million in 2018, then soared by 77.72% to $9.1 million in 2019, then soared by 481.86% to $52.8 million in 2020, then jumped by 437.78% to $284.0 million in 2021.
• The last three Raw Materials figures came in at $284.0 million (Q4 2021), $203.9 million (Q2 2021), and $52.8 million (Q4 2020), per Business Quant data.

Peer Comparison